ASEAN–South Korea FTA – Origin Cumulation Pharmaceutical Products

Quelle: https://www.wto.org/english/tratop_e/region_e/region_e.htm

The origin cumulation within the ASEAN–South Korea Free Trade Agreement allows raw materials and components produced in other ASEAN member states to be counted towards the origin determination of pharmaceutical products.

Related Terms

You might also be interested in these terms

ASEAN–South Korea FTA

The ASEAN–South Korea FTA is a free trade agreement between the ASEAN countries and South Korea aimed at promoting trade and economic cooperation, red...

Learn more

ASEAN–South Korea FTA – Origin Cumulation Toys

The origin cumulation under the ASEAN–South Korea Free Trade Agreement allows raw materials or semi-finished products from one ASEAN country to be pro...

Learn more

ASEAN–South Korea FTA – Origin Cumulation Shoes

Origin cumulation under the ASEAN–South Korea Free Trade Agreement refers to the regulation that allows materials from ASEAN countries and South Korea...

Learn more

CAFTA-DR – Origin Cumulation Pharmaceutical Products

CAFTA-DR – Origin cumulation refers to the mechanism under the Central America Free Trade Agreement – Dominican Republic that allows countries to appl...

Learn more

EFTA–Chile FTA – Origin Cumulation Pharmaceutical Products

The EFTA-Chile Free Trade Agreement allows for origin cumulation for pharmaceutical products, meaning that these products can benefit from the accumul...

Learn more

EFTA–China FTA – Origin Cumulation Pharmaceutical Products

Origin cumulation under the EFTA–China FTA refers to the regulation that allows materials and products from certain EFTA states and China to be aggreg...

Learn more